docetaxel anhydrous has been researched along with Experimental Mammary Neoplasms in 55 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (14.55) | 18.2507 |
| 2000's | 12 (21.82) | 29.6817 |
| 2010's | 32 (58.18) | 24.3611 |
| 2020's | 3 (5.45) | 2.80 |
| Authors | Studies |
|---|---|
| Enteshari, S; Hashemi-Beni, B; Hassanzadeh, F; Minaiyan, M; Varshosaz, J | 1 |
| Chaudhari, D; Ghadi, R; Jain, S; Kaushik, L; Kuche, K; Malik, R; Panjeta, A; Preet, S; Raza, K; Srivastava, S | 1 |
| Dou, JX; Jiang, W; Li, SY; Li, XQ; Liu, H; Wang, L; Wang, YC | 1 |
| Chen, H; Liu, B; Liu, F; Liu, Z; Mao, C; Miao, Z; Shi, T; Wan, M; Wang, X; Wang, Y; Wei, J; Zhang, H | 1 |
| Liu, Y; Sun, G; Sun, L; Wang, K; Xing, H | 1 |
| Han, X; He, W; Lv, Y; Qin, C; Xin, X; Yang, L; Yang, X; Yin, L; Zhang, L | 1 |
| Dong, XY; Lang, TQ; Li, YP; Yin, Q; Zhang, PC | 1 |
| Amiri, Z; Edalatkhah, H; Hejazi, E; Hejazi, J; Houshyari, M; Idali, F; Jeddi-Tehrani, M; Kimiagar, M; Nasrollahzadeh, J; Tavakoli, M | 1 |
| Enteshari, S; Hassanzadeh, F; Minayian, M; Varshosaz, J | 1 |
| Cheng, W; Huang, L; Liang, C; Liu, G; Mei, L; Nie, J; Peng, Y; Zeng, X; Zhang, L; Zhu, D | 1 |
| Chen, L; Chen, X; Li, W; Peng, J; Qian, Z; Yang, Q; Zhang, L | 1 |
| Allen, RJ; Bishop, RT; de Ridder, D; Idris, AI; Lefley, DV; Marino, S; Ottewell, PD; Sims, AH; Wang, N | 1 |
| Chen, H; Li, P; Ran, H; Wan, J; Wang, Z; Yang, Q; Zhang, L | 1 |
| Gong, M; Li, Y; Wang, S; Yuan, Y; Zhang, Q; Zhao, Q; Zheng, J | 1 |
| Czepas, J; Gwoździński, K; Koceva-Chyła, A; Piasecka-Zelga, J; Pieniążek, A; Tabaczar, S | 1 |
| Ernsting, MJ; Hoang, B; Li, SD; Murakami, M; Roy, A; Undzys, E | 1 |
| Cai, KQ; Domanitskaya, N; Egleston, B; Foster, K; Hopper-Borge, E; Jacobs, J; Mahdaviyeh, Y; Malofeeva, E; Paulose, C; Peiffer, E; Wangari-Talbot, J; Zhou, Y | 1 |
| Arra, C; Barbieri, A; Bimonte, S; Conte, C; Luciano, A; Palma, G; Quaglia, F; Rea, D; Tirino, P; Ungaro, F | 1 |
| Chen, H; Deng, Q; Du, N; Guo, L; Guo, N; Hu, C; Hu, Y; Liu, D; Liu, Y; Shi, M; Wang, T; Yang, Z; Yu, M | 1 |
| Gao, D; Gao, L; Jia, B; Liu, Z; Sun, X; Wang, F; Yu, X; Zhang, C | 1 |
| Chang, M; Guan, Y; Lin, G; Lu, S; Shao, W; Wei, T; Zhang, F; Zuo, T | 1 |
| Cao, M; Li, Y; Meng, Q; Sun, H; Xu, P; Yin, Q; Yu, H; Zhang, Y; Zhang, Z | 1 |
| Aurisicchio, L; Carollo, V; De Santis, R; Ferrara, FF; Roscilli, G; Spagnoli, L; Vesci, L | 1 |
| Beijnen, JH; Hendrikx, JJ; Lagas, JS; Rosing, H; Rottenberg, S; Schellens, JH; Schinkel, AH; Song, JY | 1 |
| Feng, B; Guo, C; Li, Y; Wang, D; Wang, T; Xu, Z; Yin, Q; Yu, H; Zhang, J; Zhang, Z | 1 |
| Blanc, C; Bougnoux, P; Chauvin, L; Chevalier, S; Domingo, I; Goupille, C; Guimaraes, C; Mahéo, K; Pinault, M | 1 |
| Bisson, JN; Dvorkin-Gheva, A; Giacomelli, AO; Girgis-Gabardo, A; Gwynne, WD; Hallett, RM; Hassell, JA; Jensen, JE | 1 |
| Cordero, A; Dougall, WC; Gomez-Miragaya, J; González-Suárez, E; Muñoz, P; Pellegrini, P; Planelles, L; Pujana, MA; Serra-Musach, J; Trinidad, EM; Yoldi, G | 1 |
| Abnous, K; Alabdollah, F; Alibolandi, M; Hadizadeh, F; Mohammadi, M; Nassirli, H; Ramezani, M; Taghdisi, SM | 1 |
| Bally, M; Daynard, T; Dedhar, S; Dragowska, W; Edwards, L; Fang, K; Gelmon, K; Kalra, J; Sutherland, BW; Warburton, C; Waterhouse, D | 1 |
| Aguilar-Mahecha, A; Alsawafi, Y; Basik, M; Buchanan, M; Gaboury, L; Hassan, S; Jahan, K; Mourskaia, AA; Muller, WJ; Salvucci, O; Siegel, PM | 1 |
| Amedio, J; Jones, B; Komarnitsky, P; Miller, GT; Wallner, BP | 1 |
| Kim, SH; Lee, DY; Lee, JH; Lee, MG; Lyuk, KC; Yang, SH | 1 |
| Treshalina, EM; Yakunina, MN | 1 |
| Borst, P; de Hoon, B; de Ronde, J; Gillet, JP; Gottesman, MM; Gribnau, J; Jaspers, JE; Jonkers, J; Jonkers, M; Kersbergen, A; Linn, SC; Lodén, M; Pajic, M; Rottenberg, S; Schouten, PC; Sol, W; van der Burg, E; Vollebergh, MA; Wesseling, J; Wessels, L; Zander, SA | 1 |
| Bleuzen, A; Bougnoux, P; Chevalier, S; Goupille, C; Mahéo, K; Richard, S; Serrière, S; Tranquart, F; Vibet, S | 1 |
| Chang, EH; Pirollo, KF; Rait, AS; Ulick, D; Xiang, L | 1 |
| Bissery, MC; Filipski, E; Granda, TG; Lévi, F; Vrignaud, P | 1 |
| Goto, N; Higuchi, S; Ohdo, S; Sakaguchi, H; Tabuchi, M; Takeuchi, A; To, H | 1 |
| Li, LS; Song, HF; Song, ST; Sun, JZ; Zhao, H; Zhu, JH | 1 |
| Ang, K; Ariga, H; Hunter, N; Mason, KA; Milas, L; Neal, R | 1 |
| Amboldi, N; Ciomei, M; Croci, V; Giavarini, R; Pesenti, E; Stellari, F | 1 |
| Buchholz, S; Engel, JB; Halmos, G; Heinrich, E; Hohla, F; Koester, F; Schally, AV; Varga, JL | 1 |
| Bissery, MC; Dykes, DJ; Harrison, SD; Waud, WR | 1 |
| Bissery, MC; Lavelle, F; Vrignaud, P | 1 |
| Bissery, MC; Fellous, A; Martinez, C; Veitia, R | 1 |
| Abbruzzese, JL; Hunter, NR; Mason, KA; Milas, L; Milas, M | 1 |
| Boucher, Y; Brekken, C; Griffon-Etienne, G; Jain, RK; Suit, HD | 1 |
| Distelmans, W; Storme, G | 1 |
| Akimoto, T; Buchmiller, L; Hunter, N; Kishi, K; Komaki, R; Mason, KA; Milas, L | 1 |
| Hunter, N; Mason, K; McBride, W; Milas, L; Petersen, S; Staab, A; Terry, N | 1 |
| Anjo, A; Bissery, MC; D'Attino, RM; Filipski, E; Granda, TG; Lévi, F; Vrignaud, P | 1 |
| Eriguchi, M; Matsuzawa, A; Nonaka, Y; Takeda, Y; Yanagie, H; Yoshizaki, I | 1 |
| Kunisue, H; Kurebayashi, J; Kurosumi, M; Otsuki, T; Sonoo, H; Tanaka, K; Yamamoto, S | 1 |
| Bissery, MC; Guénard, D; Guéritte-Voegelein, F; Lavelle, F | 1 |
55 other study(ies) available for docetaxel anhydrous and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
Tissue Distribution and Systemic Toxicity Evaluation of Raloxifene Targeted Polymeric Micelles of Poly (Styrene-Maleic Acid)-Poly (Amide- Ether-Ester-Imide)-Poly (Ethylene Glycol) Loaded With Docetaxel in Breast Cancer Bearing Mice.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Docetaxel; Drug Carriers; Female; Humans; Maleates; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Micelles; Polyethylene Glycols; Polystyrenes; Raloxifene Hydrochloride; Random Allocation; Selective Estrogen Receptor Modulators; Tissue Distribution | 2019 |
Exploration of docetaxel palmitate and its solid lipid nanoparticles as a novel option for alleviating the rising concern of multi-drug resistance.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Survival; Docetaxel; Drug Liberation; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Erythrocytes; Female; Humans; Lipids; Male; Mammary Neoplasms, Experimental; MCF-7 Cells; Mice, Inbred BALB C; Nanoparticles; Rats, Wistar; Serum Albumin, Human | 2020 |
Polyphosphoestered Nanomedicines with Tunable Surface Hydrophilicity for Cancer Drug Delivery.
Topics: Animals; Antineoplastic Agents; Cell Proliferation; Docetaxel; Drug Delivery Systems; Drug Screening Assays, Antitumor; Hydrophobic and Hydrophilic Interactions; Mammary Neoplasms, Experimental; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Mice, Nude; Molecular Structure; Nanomedicine; Nanoparticles; Particle Size; Polyphosphates; Surface Properties | 2020 |
Deep Penetration of Nanolevel Drugs and Micrometer-Level T Cells Promoted by Nanomotors for Cancer Immunochemotherapy.
Topics: Animals; Breast Neoplasms; Cell Proliferation; Docetaxel; Female; Humans; Immunotherapy; Mammary Neoplasms, Experimental; MCF-7 Cells; Mice; Nanostructures; Nitric Oxide; T-Lymphocytes; Tumor Microenvironment | 2021 |
Her-2 expression regulated by downregulation of miR-9 and which affects chemotherapeutic effect in breast cancer.
Topics: 3' Untranslated Regions; Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Docetaxel; Down-Regulation; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Kaplan-Meier Estimate; Mammary Neoplasms, Experimental; MCF-7 Cells; Mice, Inbred C57BL; MicroRNAs; Receptor, ErbB-2; Taxoids | 2017 |
Cytosolic co-delivery of miRNA-34a and docetaxel with core-shell nanocarriers via caveolae-mediated pathway for the treatment of metastatic breast cancer.
Topics: Animals; Antineoplastic Agents; Apoptosis; Caveolae; Cell Line, Tumor; Cell Movement; Cytosol; Docetaxel; Drug Carriers; Drug Delivery Systems; Endocytosis; Humans; Mammary Neoplasms, Experimental; Mice; MicroRNAs; Nanoparticles; Neoplasm Metastasis; Rats; RNA Interference; RNA Stability; Spheroids, Cellular; Taxoids; Tissue Distribution | 2017 |
Co-delivery of docetaxel and silibinin using pH-sensitive micelles improves therapy of metastatic breast cancer.
Topics: Acrylic Resins; Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Proliferation; Docetaxel; Dose-Response Relationship, Drug; Drug Delivery Systems; Drug Screening Assays, Antitumor; Female; Hydrogen-Ion Concentration; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Nude; Micelles; Polyethylene Glycols; Silybin; Silymarin; Structure-Activity Relationship; Taxoids; Tumor Cells, Cultured | 2017 |
Investigating the Antiangiogenic, Anti-drug Resistance and Apoptotic Effects of Soy Isoflavone Extract Alone or in Combination with Docetaxel on Murine 4T1 Breast Tumor Model.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Docetaxel; Drug Resistance, Neoplasm; Eating; Female; Gene Expression Regulation, Neoplastic; Glycine max; Isoflavones; Mammary Neoplasms, Experimental; Mice, Inbred BALB C; Plant Extracts; Survival Rate; Taxoids; Transcription Factor RelA; Vascular Endothelial Growth Factor Receptor-2 | 2017 |
Antitumor activity of raloxifene-targeted poly(styrene maleic acid)-poly (amide-ether-ester-imide) co-polymeric nanomicelles loaded with docetaxel in breast cancer-bearing mice.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Docetaxel; Female; Kaplan-Meier Estimate; Maleates; Mammary Neoplasms, Experimental; Mice, Inbred BALB C; Micelles; Nanoparticles; Polystyrenes; Raloxifene Hydrochloride; Tumor Burden | 2018 |
A multifunctional nanoplatform for cancer chemo-photothermal synergistic therapy and overcoming multidrug resistance.
Topics: Animals; Antineoplastic Agents; Docetaxel; Dopamine; Drug Liberation; Drug Resistance, Neoplasm; Female; Humans; Lactic Acid; Mammary Neoplasms, Experimental; MCF-7 Cells; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Phototherapy; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Taxoids; Vitamin E | 2018 |
α-Lipoic acid stabilized DTX/IR780 micelles for photoacoustic/fluorescence imaging guided photothermal therapy/chemotherapy of breast cancer.
Topics: Animals; Antineoplastic Agents; Docetaxel; Female; Humans; Indoles; Mammary Neoplasms, Experimental; MCF-7 Cells; Mice; Mice, Inbred BALB C; Micelles; Optical Imaging; Photoacoustic Techniques; Photochemotherapy; Polyesters; Polyethylene Glycols; Taxoids; Thioctic Acid | 2018 |
Pharmacological inhibition of the IKKε/TBK-1 axis potentiates the anti-tumour and anti-metastatic effects of Docetaxel in mouse models of breast cancer.
Topics: Aminopyridines; Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Line, Tumor; Docetaxel; Drug Synergism; Female; Humans; I-kappa B Kinase; Mammary Neoplasms, Experimental; MCF-7 Cells; Mice; Mice, Inbred BALB C; Mice, Nude; Protein Serine-Threonine Kinases; RAW 264.7 Cells | 2019 |
Polypyrrole-coated phase-change liquid perfluorocarbon nanoparticles for the visualized photothermal-chemotherapy of breast cancer.
Topics: Animals; Coated Materials, Biocompatible; Docetaxel; Female; Fluorocarbons; HeLa Cells; Humans; Hyperthermia, Induced; Infrared Rays; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Nanoparticles; Phototherapy; Polymers; Pyrroles | 2019 |
Development of synthetic high-density lipoprotein-based ApoA-I mimetic peptide-loaded docetaxel as a drug delivery nanocarrier for breast cancer chemotherapy.
Topics: Animals; Antineoplastic Agents; Apolipoprotein A-I; Biomimetic Materials; Delayed-Action Preparations; Docetaxel; Drug Carriers; Epithelial Cells; Female; Humans; Mammary Neoplasms, Experimental; MCF-7 Cells; Mice; Nanoparticles; Optical Imaging; Peptides; Scavenger Receptors, Class B | 2019 |
Quercetin attenuates oxidative stress in the blood plasma of rats bearing DMBA-induced mammary cancer and treated with a combination of doxorubicin and docetaxel.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Doxorubicin; Female; Mammary Neoplasms, Experimental; Oxidative Stress; Quercetin; Rats; Rats, Sprague-Dawley; Taxoids | 2013 |
Carboxymethylcellulose-based and docetaxel-loaded nanoparticles circumvent P-glycoprotein-mediated multidrug resistance.
Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Carboxymethylcellulose Sodium; Cell Line, Tumor; Docetaxel; Drug Delivery Systems; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Inhibitory Concentration 50; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred NOD; Mice, SCID; Nanoparticles; Phenotype; Polymers; RNA, Messenger; Taxoids | 2014 |
Abcc10 status affects mammary tumour growth, metastasis, and docetaxel treatment response.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Docetaxel; Drug Resistance, Neoplasm; Female; Gene Expression; Humans; Lung Neoplasms; Mammary Neoplasms, Experimental; Mice; Mice, Knockout; Mice, SCID; Multidrug Resistance-Associated Proteins; Neoplasm Transplantation; Paclitaxel; Receptor, ErbB-2; Receptors, Estrogen; Taxoids; Tissue Array Analysis; Tumor Burden | 2014 |
Antitumor activity of PEGylated biodegradable nanoparticles for sustained release of docetaxel in triple-negative breast cancer.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Animals; Antineoplastic Agents; beta-Cyclodextrins; Blood Proteins; Cell Line, Tumor; Cell Survival; Delayed-Action Preparations; Docetaxel; Ethylene Glycols; Female; Humans; Mammary Neoplasms, Experimental; Mice, Nude; Nanoparticles; Polyesters; Powders; Taxoids; Triple Negative Breast Neoplasms; Tumor Burden | 2014 |
β2-AR signaling controls trastuzumab resistance-dependent pathway.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Line, Tumor; Cyclophosphamide; Docetaxel; Drug Resistance, Neoplasm; Epirubicin; Female; Humans; Mammary Neoplasms, Experimental; MCF-7 Cells; Mice; Mice, Nude; Receptor, ErbB-2; Receptors, Adrenergic, beta-2; Signal Transduction; Taxoids; Trastuzumab | 2016 |
Molecular imaging of tumor-infiltrating macrophages in a preclinical mouse model of breast cancer.
Topics: Animals; Antineoplastic Agents; Cell Line; Cell Line, Tumor; Diphosphonates; Docetaxel; Female; Imidazoles; Lectins, C-Type; Lung Neoplasms; Macrophages; Mammary Neoplasms, Experimental; Mannose Receptor; Mannose-Binding Lectins; Mice; Mice, Inbred BALB C; Receptors, Cell Surface; Sensitivity and Specificity; Spectroscopy, Near-Infrared; Taxoids; Zoledronic Acid | 2015 |
RGD-modified pH-sensitive liposomes for docetaxel tumor targeting.
Topics: Animals; Antineoplastic Agents; Cell Survival; Docetaxel; Drug Carriers; Drug Delivery Systems; Female; Humans; Hydrogen-Ion Concentration; Liposomes; Mammary Neoplasms, Experimental; MCF-7 Cells; Mice; Mice, Inbred BALB C; Mice, Nude; Oligopeptides; Particle Size; Taxoids; Tissue Distribution; Xenograft Model Antitumor Assays | 2015 |
Shrapnel nanoparticles loading docetaxel inhibit metastasis and growth of breast cancer.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Docetaxel; Drug Carriers; Drug Compounding; Drug Screening Assays, Antitumor; Female; Liposomes; Lung Neoplasms; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Nude; Micelles; Molecular Structure; Nanoparticles; Neoplasm Proteins; Particle Size; Phosphatidylcholines; Polyethylene Glycols; Random Allocation; Rats, Sprague-Dawley; Taxoids; Tissue Distribution; Tocopherols; Tumor Microenvironment | 2015 |
Trastuzumab and docetaxel in a preclinical organotypic breast cancer model using tissue slices from mammary fat pad: Translational relevance.
Topics: Adipose Tissue; Animals; Antineoplastic Agents; Apoptosis; Cell Proliferation; Cell Survival; Docetaxel; Female; Humans; Immunohistochemistry; Mammary Neoplasms, Experimental; MCF-7 Cells; Mice; Mice, SCID; Organ Culture Techniques; Taxoids; Trastuzumab; Xenograft Model Antitumor Assays | 2015 |
Ritonavir inhibits intratumoral docetaxel metabolism and enhances docetaxel antitumor activity in an immunocompetent mouse breast cancer model.
Topics: Animals; Antineoplastic Agents; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Cytochrome P-450 Enzyme System; Docetaxel; Drug Synergism; Female; HIV Protease Inhibitors; Immunocompetence; Mammary Neoplasms, Experimental; Mice; Ritonavir; Taxoids | 2016 |
Cooperative Treatment of Metastatic Breast Cancer Using Host-Guest Nanoplatform Coloaded with Docetaxel and siRNA.
Topics: Animals; Antineoplastic Agents; Blotting, Western; Breast Neoplasms; Cell Death; Cell Line, Tumor; Docetaxel; Endocytosis; Female; Gene Knockdown Techniques; Gold; Humans; Lung Neoplasms; Mammary Neoplasms, Experimental; Mice; Nanotubes; RNA, Small Interfering; Spectrophotometry, Ultraviolet; Static Electricity; Taxoids; Temperature; Time Factors | 2016 |
Long chain n-3 polyunsaturated fatty acids increase the efficacy of docetaxel in mammary cancer cells by downregulating Akt and PKCε/δ-induced ERK pathways.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Docetaxel; Docosahexaenoic Acids; Dose-Response Relationship, Drug; Down-Regulation; Drug Resistance, Neoplasm; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Female; Humans; Mammary Neoplasms, Experimental; Methylnitrosourea; Phosphorylation; Protein Kinase C-delta; Protein Kinase C-epsilon; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Rats, Sprague-Dawley; RNA Interference; Signal Transduction; Taxoids; Time Factors; Transfection; Tumor Burden | 2016 |
Serotonin transporter antagonists target tumor-initiating cells in a transgenic mouse model of breast cancer.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Docetaxel; Drug Synergism; Female; Humans; Mammary Neoplasms, Experimental; Mice, Transgenic; Neoplastic Stem Cells; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Sertraline; Spheroids, Cellular; Taxoids | 2016 |
RANK Signaling Blockade Reduces Breast Cancer Recurrence by Inducing Tumor Cell Differentiation.
Topics: Animals; Apoptosis; Ataxin-1; Cell Differentiation; Docetaxel; Female; Humans; Lung Neoplasms; Mammary Neoplasms, Experimental; Mammary Tumor Virus, Mouse; Mice; Mice, Inbred C57BL; Neoplasm Recurrence, Local; Neoplastic Stem Cells; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; Signal Transduction; Taxoids; Transcription Factor AP-2 | 2016 |
Dextran-poly lactide-co-glycolide polymersomes decorated with folate-antennae for targeted delivery of docetaxel to breast adenocarcinima in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Cell Survival; Dextrans; Docetaxel; Drug Carriers; Drug Liberation; Folic Acid; Humans; Mammary Neoplasms, Experimental; MCF-7 Cells; Mice, Inbred BALB C; Molecular Targeted Therapy; Polyesters; Taxoids; Tissue Distribution; Treatment Outcome | 2016 |
QLT0267, a small molecule inhibitor targeting integrin-linked kinase (ILK), and docetaxel can combine to produce synergistic interactions linked to enhanced cytotoxicity, reductions in P-AKT levels, altered F-actin architecture and improved treatment outc
Topics: Actins; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Line, Tumor; Docetaxel; Drug Synergism; Female; Humans; Mammary Neoplasms, Experimental; Mice; Mice, Nude; Neoplasm Transplantation; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-akt; Taxoids | 2009 |
CXCR4 peptide antagonist inhibits primary breast tumor growth, metastasis and enhances the efficacy of anti-VEGF treatment or docetaxel in a transgenic mouse model.
Topics: Animals; Antineoplastic Agents; Blotting, Western; Cell Division; Disease Models, Animal; Docetaxel; Immunohistochemistry; Male; Mammary Neoplasms, Experimental; Mice; Mice, Transgenic; Neoplasm Metastasis; Peptides; Receptors, CXCR4; Taxoids; Vascular Endothelial Growth Factor A | 2011 |
Anticancer activity of stabilized palifosfamide in vivo: schedule effects, oral bioavailability, and enhanced activity with docetaxel and doxorubicin.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biological Availability; Disease-Free Survival; Docetaxel; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Female; Ifosfamide; Injections, Intravenous; Leukemia, Experimental; Lysine; Male; Mammary Neoplasms, Experimental; Mice; Mice, Nude; Phosphoramide Mustards; Rats; Rats, Sprague-Dawley; Taxoids; Xenograft Model Antitumor Assays | 2012 |
Effects of morin on the pharmacokinetics of docetaxel in rats with 7,12-dimethylbenz[a]anthracene (DMBA)-induced mammary tumors.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Administration, Oral; Animals; Antineoplastic Agents, Phytogenic; Area Under Curve; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromatography, High Pressure Liquid; Docetaxel; Female; Flavonoids; Half-Life; Humans; Injections, Intravenous; Intestinal Mucosa; Liver; Mammary Neoplasms, Experimental; Mass Spectrometry; Rats; Taxoids | 2011 |
Systemic taxotere chemotherapy for metastatic tumor pleurisy in cats with spontaneous breast cancer.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cats; Disease Progression; Docetaxel; Doxorubicin; Drug Administration Schedule; Female; Mammary Neoplasms, Experimental; Neoplasm Metastasis; Pleura; Pleurisy; Taxoids; Treatment Outcome | 2011 |
Impact of intertumoral heterogeneity on predicting chemotherapy response of BRCA1-deficient mammary tumors.
Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; BRCA1 Protein; Breast Neoplasms; Cisplatin; Docetaxel; Female; Gene Expression Profiling; Mammary Neoplasms, Experimental; Mice; Mice, Transgenic; Randomized Controlled Trials as Topic; Taxoids | 2012 |
Non-invasive quantification of tumor vascular architecture during docetaxel-chemotherapy.
Topics: Adult; Aged; Animals; Antineoplastic Agents; Breast Neoplasms; Docetaxel; Female; Humans; Mammary Neoplasms, Experimental; Middle Aged; Neoplasm Staging; Neovascularization, Pathologic; Rats; Regional Blood Flow; Taxoids; Treatment Outcome; Tumor Burden; Ultrasonography | 2012 |
Tumor-targeting, systemically delivered antisense HER-2 chemosensitizes human breast cancer xenografts irrespective of HER-2 levels.
Topics: Animals; Antineoplastic Agents, Phytogenic; Docetaxel; Female; Folic Acid; Genes, erbB-2; Genetic Therapy; Genetic Vectors; Humans; Liposomes; Mammary Neoplasms, Experimental; Mice; Oligonucleotides, Antisense; Paclitaxel; Taxoids | 2002 |
[Rhythm of expression of BCL-2 protein of MA13/C mammaryadenocarcinoma bearing-mice].
Topics: Adenocarcinoma; Animals; Antineoplastic Agents, Phytogenic; Bone Marrow; Bone Marrow Diseases; Chronotherapy; Circadian Rhythm; Docetaxel; Gene Expression Regulation, Neoplastic; Genes, bcl-2; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Neoplasm Proteins; Neoplasm Transplantation; Proto-Oncogene Proteins c-bcl-2; Taxoids | 2003 |
Therapeutic index by combination of adriamycin and docetaxel depends on dosing time in mice.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Cell Division; Cell Growth Processes; Cell Line, Tumor; Docetaxel; Doxorubicin; Drug Administration Schedule; G2 Phase; Leukocyte Count; Leukopenia; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred ICR; Taxoids | 2005 |
[Inhibitory effect of antisense oligodeoxynucleotides targeting HER-2 mRNA on growth of breast cancer: experiment in vivo with mice].
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Docetaxel; Dose-Response Relationship, Drug; Female; Humans; Injections, Intravenous; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Nude; Oligodeoxyribonucleotides, Antisense; Receptor, ErbB-2; RNA, Messenger; Taxoids; Time Factors; Tumor Burden; Xenograft Model Antitumor Assays | 2006 |
CpG oligodeoxynucleotides are potent enhancers of radio- and chemoresponses of murine tumors.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; DNA; Docetaxel; Drug Synergism; Female; Lymphocytes, Tumor-Infiltrating; Male; Mammary Neoplasms, Experimental; Mice; Neoplasms, Experimental; Oligodeoxyribonucleotides; Sarcoma, Experimental; Taxoids | 2006 |
Antitumor activity of edotecarin in breast carcinoma models.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carbazoles; Cell Line, Tumor; Cell Proliferation; Docetaxel; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Humans; Indoles; Inhibitory Concentration 50; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Nude; Rats; Rats, Sprague-Dawley; Taxoids; Topoisomerase I Inhibitors | 2007 |
Potentiation of mammary cancer inhibition by combination of antagonists of growth hormone-releasing hormone with docetaxel.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Docetaxel; Drug Synergism; Drug Therapy, Combination; Female; Growth Hormone-Releasing Hormone; Humans; Mammary Neoplasms, Experimental; Mice; Mice, Nude; Taxoids; Transplantation, Heterologous | 2007 |
Response of human tumor xenografts in athymic nude mice to docetaxel (RP 56976, Taxotere).
Topics: Animals; Antineoplastic Agents, Phytogenic; Colonic Neoplasms; Docetaxel; Drugs, Investigational; Female; Humans; Lung Neoplasms; Mammary Neoplasms, Experimental; Melanoma; Mice; Mice, Nude; Neoplasm Transplantation; Ovarian Neoplasms; Paclitaxel; Taxoids; Transplantation, Heterologous | 1995 |
Preclinical profile of docetaxel (taxotere): efficacy as a single agent and in combination.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Colonic Neoplasms; Docetaxel; Female; Humans; Leukemia P388; Male; Mammary Neoplasms, Experimental; Melanoma, Experimental; Mice; Mice, Inbred Strains; Neoplasms, Experimental; Paclitaxel; Taxoids | 1995 |
Tau expression in model adenocarcinomas correlates with docetaxel sensitivity in tumour-bearing mice.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Carcinoma; Docetaxel; Drug Resistance, Neoplasm; Female; Humans; Immunoblotting; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Nude; Microtubule-Associated Proteins; Neoplasm Proteins; Paclitaxel; Pancreatic Neoplasms; Polymerase Chain Reaction; RNA, Messenger; tau Proteins; Taxoids; Tubulin | 1998 |
Docetaxel enhances tumor radioresponse in vivo.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Survival; Combined Modality Therapy; Docetaxel; Female; Intestinal Mucosa; Jejunum; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Paclitaxel; Radiotherapy Dosage; Taxoids; Transplantation, Isogeneic; Whole-Body Irradiation | 1997 |
Taxane-induced apoptosis decompresses blood vessels and lowers interstitial fluid pressure in solid tumors: clinical implications.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Blood Vessels; Brain Neoplasms; Docetaxel; Female; Glioblastoma; Humans; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Mice, Nude; Neoplasm Transplantation; Neoplasms, Experimental; Paclitaxel; Pressure; Sarcoma, Experimental; Specific Pathogen-Free Organisms; Taxoids; Tumor Cells, Cultured | 1999 |
The effect of pretreatment with docetaxel (taxotere; RP 56976) on irradiated subcutaneous MA 16/C murine tumors.
Topics: Animals; Chemotherapy, Adjuvant; Docetaxel; Female; Injections, Intravenous; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Paclitaxel; Premedication; Radiation-Sensitizing Agents; Radiotherapy, Adjuvant; Skin Neoplasms; Taxoids | 1999 |
Effect of docetaxel on the therapeutic ratio of fractionated radiotherapy in vivo.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Cell Division; Combined Modality Therapy; Docetaxel; Dose Fractionation, Radiation; Growth Inhibitors; Intestinal Mucosa; Jejunum; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Neoplasm Transplantation; Paclitaxel; Radiation-Sensitizing Agents; Taxoids | 1999 |
Enhancement of tumor radioresponse by docetaxel: Involvement of immune system.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Survival; Combined Modality Therapy; Docetaxel; Immune System; Immune Tolerance; Immunocompetence; Killer Cells, Natural; Lymphocytes, Tumor-Infiltrating; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Muscle Neoplasms; Paclitaxel; Radiation-Sensitizing Agents; T-Lymphocytes, Helper-Inducer; Taxoids; Whole-Body Irradiation | 2001 |
Experimental chronotherapy of mouse mammary adenocarcinoma MA13/C with docetaxel and doxorubicin as single agents and in combination.
Topics: Adenocarcinoma; Animals; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Circadian Rhythm; Docetaxel; Doxorubicin; Drug Administration Schedule; Heart; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Microscopy, Electron; Myocardium; Paclitaxel; Taxoids | 2001 |
Docetaxel alone or orally combined with 5-fluorouracil and its derivatives: effects on mouse mammary tumor cell line MM2 in vitro and in vivo.
Topics: Administration, Oral; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Docetaxel; Drug Synergism; Female; Floxuridine; Fluorouracil; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Paclitaxel; Prodrugs; Taxoids; Thymidine Phosphorylase; Tumor Cells, Cultured; Up-Regulation | 2001 |
Combined effects of docetaxel and fluoropyrimidines on tumor growth and expression of interleukin-6 and thymidine phosphorylase in breast cancer xenografts.
Topics: Animals; Antimetabolites, Antineoplastic; Breast Neoplasms; Cachexia; Docetaxel; Drug Interactions; Female; Floxuridine; Gene Expression Regulation, Neoplastic; Humans; Interleukin-6; Mammary Neoplasms, Experimental; Mice; Mice, Nude; Paclitaxel; Taxoids; Tegafur; Thymidine Phosphorylase; Transplantation, Heterologous; Tumor Cells, Cultured | 2001 |
Experimental antitumor activity of taxotere (RP 56976, NSC 628503), a taxol analogue.
Topics: Adenocarcinoma; Alkaloids; Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Intraductal, Noninfiltrating; Colonic Neoplasms; Docetaxel; Female; Leukemia, Experimental; Lung Neoplasms; Male; Mammary Neoplasms, Experimental; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Neoplasm Transplantation; Neoplasms, Experimental; Osteosarcoma; Paclitaxel; Pancreatic Neoplasms; Sarcoma, Experimental; Taxoids | 1991 |